Clinical Diagnostics Fuel Growth in Digital PCR Technology

June 06, 2018

WELLESLEY, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Development in the clinical diagnostics space and novel uses in agriculture, food and environmental science are driving growth in the global market for digital polymerase chain reaction (PCR) technology. A new BCC Research study forecasts this market to reach $746.0 million by 2022 and examines it by digital PCR equipment and consumables.

Digital PCR has also been integrated in next-generation sequencing workflows to detect the quality of samples. It is used to calibrate the quantification of genomic and exomic DNA before sequencing, leading to more confidence in results and enabling sequencing to proceed with lower-quality samples. From $425.0 million in 2017, this market is projected to expand at a five-year compound annual growth rate (CAGR) of 11.9%, according to BCC Research’s report, Digital Polymerase Chain Reaction (PCR) Technology: Global Markets.

In the pursuit of ways to generate revenue, many companies are pushing forward with digital PCR research and development. Between the development of new digital PCR assays, consumable technologies and sample-preparation techniques, numerous opportunities exist for businesses to embrace the rise of digital PCR within the marketplace.

Research Highlights

  • Driven by new applications, the markets for digital PCR equipment and consumables will grow by CAGRs of 9.5% and 14.9%, respectively.
  • Because it can detect low copy numbers in complex matrices, digital PCR is a valuable tool for the monitoring and quality control of plants and food.
  • The ability of digital PCR to precisely measure alleles has led to numerous research insights and diagnostic tools that require only a simple blood sample.

“The current explosive growth in digital PCR is attributable to several key developments that will influence its development and affect its trajectory throughout the marketplace,” said Todd Graham, BCC Research analyst and author of this report. “For example, due to its precision of measurement, digital PCR is another weapon in the fight against cancer. A number of companion diagnostics in the pipeline use digital PCR to improve prognosis and diagnosis for treatment.”

Clinical Diagnostics Bolster Digital PCR Growth

Digital PCR has found a niche in the clinical diagnostics space. Growth in this sector has also been driven by the development of new assay and sample preparation technologies to complement digital PCR. This growth and refinement of the technology will drive the use of digital PCR consumables in all sectors of the life sciences and support industrial growth for at least the next five years.

Editors/reporters requesting analyst interviews should contact Eric Surber at


Digital Polymerase Chain Reaction (PCR) Technology: Global Markets( BIO137B )
Publish Date: May 2018    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.